Organization and Basis of Presentation (Details Narrative) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Aug. 17, 2021 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Nov. 20, 2023 |
|
| Accumulated deficit | $ 56.5 | |||
| Common stock shares, par value | $ 0.0001 | $ 0.0001 | ||
| Exercise price per share | $ 2.82 | |||
| Cash and cash equivalents | $ 4.7 | |||
| Net Cash Used In Operation | $ 2.7 | $ 6.4 | ||
| Warrant exercise price | $ 112.00 | |||
| Warrants issued | 24,106 | |||
| Initial Public Offering [Member] | ||||
| Common stock shares, par value | $ 0.0001 | |||
| Warrants to purchase one share of common stock | 160,714 | |||
| Sale of stock | 160,714 | |||
| Exercise price per share | $ 112.00 | |||
| Warrant exercise price | 112.00 | |||
| Combined Offering Price | $ 112.00 | |||
| Warrants issued | 184,820 | |||
| Gross proceeds from warrants purchase of common stock | $ 15.4 | |||
| Issuance costs | $ 2.6 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cumulative earnings (deficits) for relevant time periods. No definition available.
|
| X | ||||||||||
- Definition The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of a derivative security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Details
|